Stay updated on Lirentelimab in Eosinophilic Esophagitis Clinical Trial
Sign up to get notified when there's something new on the Lirentelimab in Eosinophilic Esophagitis Clinical Trial page.

Latest updates to the Lirentelimab in Eosinophilic Esophagitis Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedAdded Revision: v3.4.2 and removed the government funding/operating status notice as well as the prior Revision: v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check21 days agoChange DetectedA government funding notice banner was added and the page revision updated from v3.4.0 to v3.4.1.SummaryDifference0.2%

- Check28 days agoChange DetectedUI changes include showing the glossary, adding labels like 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data', and updating the revision tag to v3.4.0.SummaryDifference0.1%

- Check42 days agoChange DetectedRevision: v3.3.4 was introduced; there are no visible user-facing changes to the Study Details page beyond the version label. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check64 days agoChange DetectedAdded a consolidated Locations section listing all study sites by state and country. Removed the individual state location subsections (e.g., Alabama Locations) and the HHS Vulnerability Disclosure link.SummaryDifference2%

- Check85 days agoChange DetectedThe page revision has been updated to v3.3.2, replacing the previous v3.3.1 entry.SummaryDifference0.0%

Stay in the know with updates to Lirentelimab in Eosinophilic Esophagitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lirentelimab in Eosinophilic Esophagitis Clinical Trial page.